SEC Form 4 · accession 0001250853-16-000184
IOVANCE BIOTHERAPEUTICS, INC. · IOVA
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Gregory T Schiffman
Officer — Chief Financial Officer
Period of report
Nov 14, 2016
Accepted (ET)
Nov 15, 2016 · 6:31 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001425205
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F1 | $7.55 | Nov 14, 2016 | A | 300,000 | A | — | Nov 14, 2026 | Common Stock | 300,000 | 300,000 | D |
Explanation of responses
- F1The option will vest as to 100,000 shares on October 3, 2017, and the remaining 200,000 shares will vest as to 25,000 shares quarterly over the next two years after October 3, 2017, provided the Reporting Person is still providing services to the Issuer on the respective dates.